Pfizer nabs first obesity approval; Alnylam, Tenaya search for heart drugs [Yahoo! Finance]
Alnylam Pharmaceuticals, Inc. (ALNY)
Last alnylam pharmaceuticals, inc. earnings: 2/6 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.alnylam.com/investor-overview
Company Research
Source: Yahoo! Finance
This story was originally published on BioPharma Dive . To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter Today, a brief rundown of news from Pfizer and Alnylam Pharmaceuticals, as well as updates from Helus Pharma and Daiichi Sankyo that you may have missed. Pfizer has won its first obesity drug approval, announcing Friday that Chinese regulators have cleared a medicine the company recently acquired partial rights to in a licensing deal. According to Pfizer, China's health authorities greenlit Severwin , formerly ecnoglutide , for weight management in adults. Pfizer last month acquired from Sciwind Biosciences exclusive commercialization rights to the drug in China, where it had already been OK'd for Type 2 diabetes. That deal was one of a series of obesity-related investments for Pfizer, which paid $10 billion for Metsera last year and reached a potentially $2 billion licensing deal with YaoPharma — Ben Fidler Tenaya Therapeutics and Al
Show less
Read more
Impact Snapshot
Event Time:
ALNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ALNY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ALNY alerts
High impacting Alnylam Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
ALNY
News
- Alnylam and Tenaya sign $1.23bn cardiovascular target discovery deal [Yahoo! Finance]Yahoo! Finance
- Tenaya Therapeutics inks $1.13 billion deal with Alnylam for heart-disease treatments [Yahoo! Finance]Yahoo! Finance
- Helix Announces Multi-Year Agreement with Alnylam to Drive Precision Medicine Development [Yahoo! Finance]Yahoo! Finance
- Alnylam's research pact worth up to $1.1B sends Tenaya higher [Seeking Alpha]Seeking Alpha
- Alnylam Reimbursement Win And Trial Progress Versus Current Valuation Signals [Yahoo! Finance]Yahoo! Finance
ALNY
Earnings
- 2/12/26 - Beat
ALNY
Sec Filings
- 3/6/26 - Form 4
- 3/6/26 - Form 4
- 3/6/26 - Form 4
- ALNY's page on the SEC website